Gilead Sciences
GILD
#134
Rank
A$233.60 B
Marketcap
A$188.40
Share price
1.80%
Change (1 day)
3.01%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): A$11.09

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is A$10.49. In 2025 the company made an earnings per share (EPS) of A$9.69 an increase over its 2024 EPS that were of A$0.54.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$11.0914.48%
2025A$9.691702.63%
2024A$0.54-91.65%
2023A$6.4423.98%
2022A$5.19-25.86%
2021A$7.004850%
2020A$0.14-97.64%
2019A$6.000.9%
2018A$5.9418.71%
2017A$5.01-64.88%
2016A$14.26-18.45%
2015A$17.4855.28%
2014A$11.26296.02%
2013A$2.8417.89%
2012A$2.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.35 17.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.85-82.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.91-72.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$39.92 280.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.48 95.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$13.22 26.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$7.82-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$24.06 129.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$5.06-51.82%๐Ÿ‡บ๐Ÿ‡ธ USA